HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Triethylamine → (4R)-3-Fluoro-4-({4-[([1,2,3]thiadiazolo[5,4-b]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-4,5-dihydro-7H-pyrrolo[3,2,1-de]-1,5-naphthyridin-7-one Dihydrochloride

HRID 15370
Print

Reaction equation

HRID 15370 reaction equation
[N:1]1[C:9]2[C:4](=[N:5][CH:6]=[C:7]([CH2:10]O)[CH:8]=2)[S:3][N:2]=1.C(N(CC)CC)C.CS([Cl:23])(=O)=O.[NH2:24][CH:25]1[CH2:30][CH2:29][N:28]([CH2:31][C@H:32]2[C:36]3=[C:37]([F:45])[CH:38]=[N:39][C:40]4[CH:41]=[CH:42][C:43](=[O:44])[N:34]([C:35]=43)[CH2:33]2)[CH2:27][CH2:26]1.C(OC(=O)NC1CCNCC1O)(C)(C)C.C(=O)([O-])[O-].[K+].[K+]>C1COCC1.CO.ClCCl.CN(C=O)C>[ClH:23].[ClH:23].[F:45][C:37]1[CH:38]=[N:39][C:40]2[CH:41]=[CH:42][C:43](=[O:44])[N:34]3[CH2:33][C@@H:32]([CH2:31][N:28]4[CH2:27][CH2:26][CH:25]([NH:24][CH2:10][C:7]5[CH:8]=[C:9]6[N:1]=[N:2][S:3][C:4]6=[N:5][CH:6]=5)[CH2:30][CH2:29]4)[C:36]=1[C:35]=23
ParticipantsProcedureSources & evidenceReaction notes

Participants

11

Reactant 6

HCID 8471TriethylamineHCID 11430Potassium CarbonateHCID 31297Methanesulfonyl chlorideHCID 21873601[1,2,3]Thiadiazolo[5,4-b]pyridin-6-ylmethanolHCID 57525698trans-4-(Boc-amino)-3-hydroxypiperidineHCID 68686964(4R)-4-[(4-amino-1-piperidinyl)methyl]-3-fluoro-4,5-dihydro-7H-pyrrolo[3,2,1-de]-1,5-naphthyridin-7-one

Product 1

HCID 68686862(4R)-3-Fluoro-4-({4-[([1,2,3]thiadiazolo[5,4-b]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-4,5-dihydro-7H-pyrrolo[3,2,1-de]-1,5-naphthyridin-7-one DihydrochlorideYield 27%

Reagents, catalysts & solvents 4

HCID 887MethanolSolventHCID 6228DimethylformamideSolventHCID 6344DichloromethaneSolventHCID 8028TetrahydrofuranSolvent

Procedure

To a solution of [1,2,3]thiadiazolo[5,4-b]pyridin-6-ylmethanol (for a synthesis see WO2003064431, Example 1(b(iv)) (28 mg, 0.166 mmol) in THF (1 ml) was added triethylamine (0.023 ml, 0.166 mmol) and then methanesulfonyl chloride (0.013 ml, 0.166 mmol) and the reaction was then stirred at room temperature for 2 h. DMF (1 ml) was then added followed by (4R)-4-[(4-amino-1-piperidinyl)methyl]-3-fluoro-4,5-dihydro-7H-pyrrolo[3,2,1-de]-1,5-naphthyridin-7-one Enantiomer 1 (50 mg, 0.166 mmol) and potassium carbonate (0.166 mmol) and the reaction was stirred at room temperature for a further 72 h before evaporation. The residue was subjected to column chromatography on silica gel using a dichloromethane, methanol gradient to provide the free base of the title compound (20 mg, 27%).

Sources & evidence

ORD record
ord-4282adf516d74e11b7fada8af21fe8a7
Source dataset
uspto-grants-2010_06
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07732461B2

Reaction notes

On this pageParticipantsProcedureSources & evidenceReaction notes